All Posts:neurodegenerative disease
-
Georgetown Co-Leads New NIH-Funded Multi-Institutional ALS Clinical Research Consortium
In an effort to disrupt the ALS clinical research landscape in the U.S., the National Institutes of Health has announced the establishment of a transformative national clinical research consortium to be co-led by researchers at Georgetown and three other institutions.
Category: News Release
-
Doctoral Students Hone Presentation Skills and Build Community at Student Research Day
Hosted by the Georgetown University Medical Center Graduate Student Organization (MCGSO) and Office of Biomedical Graduate Education (BGE), Student Research Day took place October 11 on the Medical Center campus.
Category: GUMC Stories
-
Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment
WASHINGTON (December 16, 2019) — A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of neuronal destruction, and a decrease in neurotoxic proteins in the brain among […]
Category: News Release
-
New Clinical Trial Will Test Cancer Drug as Alzheimer's Treatment
The following is a press release issued by the ADDF: NEW YORK (September 29, 2016) – The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD,
Category: News Release
-
Removing Protein “Garbage” in Nerve Cells May Help Control Two Neurodegenerative Diseases
Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases — amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) — and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.
Category: News Release